The actions of GIP and GLP1 on liver, muscle and adipose tissue, in the control of glucose and lipid homeostasis, are discussed in the context of plausible mechanisms of action
In the same study population, a higher HR was also associated with a greater incidence of new-onset or progressive nephropathy and retinopathy [38]
Trials for products to treat obesity and overweight enroll patients at an extraordinary rapid pace
Some people notice a big drop in their hunger and cravings, while others may not feel as much of a change
My work focuses on evidence-based obesity care, including nutrition therapy, behavior change support, and clinical guidance for patients using incretin-based therapies
Appetite, Satiety, and Reward Pathways GLP-1 agonists act in the hypothalamus and brainstem to enhance satiety signaling and reduce food reward